| human | Q5 |
| P735 | given name | Chelsea | Q1069106 |
| Chelsea | Q1069106 | ||
| P106 | occupation | researcher | Q1650915 |
| Q38540298 | 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the Ame |
| Q49789131 | 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association |
| Q97596972 | A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage |
| Q30992330 | A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential met |
| Q73757244 | A new pocket-sized transcranial ultrasound device (NeuroDop): comparison with standard TCD |
| Q30417276 | A trial of imaging selection and endovascular treatment for ischemic stroke |
| Q30425779 | APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study |
| Q50139050 | Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population. |
| Q30411115 | Acute Stroke Imaging Research Roadmap II. |
| Q75319552 | Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies |
| Q49119509 | Acute ischemic stroke trials |
| Q46127424 | Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome |
| Q31152222 | Acute stroke imaging research roadmap |
| Q33224420 | Advanced MR imaging of acute stroke: the University of California at Los Angeles endovascular therapy experience |
| Q53822422 | Advances in Stroke 2017. |
| Q34107372 | Advances in neuroimaging of acute stroke. |
| Q38676915 | Advances in stroke: Imaging 2013. |
| Q48697107 | Advances in stroke: imaging |
| Q44026712 | Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke |
| Q48766698 | Angiotensin 2 type 2 receptor activity and ischemic stroke severity |
| Q88040310 | Apparent Diffusion Coefficient Signal Intensity Ratio Predicts the Effect of Revascularization on Ischemic Cerebral Edema |
| Q64228297 | Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis |
| Q39386180 | Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage |
| Q50077112 | Author response: Ischemic Lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage |
| Q33424249 | Back to the future: reconsidering the hemodynamics of cerebral ischemia |
| Q30882783 | Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. |
| Q31143094 | Beyond tissue plasminogen activator: mechanical intervention in acute stroke |
| Q33684529 | Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. |
| Q30416687 | Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage |
| Q34982195 | CT and MRI early vessel signs reflect clot composition in acute stroke |
| Q61891188 | Chapter 11 Rapid Clinical Evaluation |
| Q30414654 | Common variants within oxidative phosphorylation genes influence risk of ischemic stroke and intracerebral hemorrhage |
| Q30370974 | Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease |
| Q34360419 | Comparison of MRI and CT for detection of acute intracerebral hemorrhage |
| Q22337014 | Definition and Evaluation of Transient Ischemic Attack |
| Q36476468 | Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial |
| Q34478232 | Design and retrospective analysis of the Los Angeles Prehospital Stroke Screen (LAPSS). |
| Q28222327 | Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention |
| Q37373759 | Development and validation of a simple conversion model for comparison of intracerebral hemorrhage volumes measured on CT and gradient recalled echo MRI. |
| Q31161803 | Developments in neuroimaging for acute ischemic stroke: diagnostic and clinical trial applications |
| Q53442027 | Diagnosis of lacunar infarcts within 6 hours of onset by clinical and CT criteria versus MRI. |
| Q41669659 | Diffusion MRI in patients with transient ischemic attacks |
| Q48713424 | Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage |
| Q48692136 | Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans |
| Q37262726 | Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System |
| Q61891150 | Early MRI and outcomes of untreated patients with mild or improving ischemic stroke |
| Q46468948 | Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. |
| Q87177293 | Endovascular treatment of acute ischemic stroke |
| Q41738914 | Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis |
| Q61649857 | Enhancing the Development and Approval of Acute Stroke Therapies |
| Q48364321 | Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack |
| Q48312391 | Establishment of primary stroke centers: a survey of physician attitudes and hospital resources |
| Q53010660 | Evidence of publication bias in reporting acute stroke clinical trials. |
| Q34002942 | Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology |
| Q40477142 | Evolving paradigms in neuroimaging of the ischemic penumbra. |
| Q45218949 | Expanding indications for statins in cerebral ischemia: a quantitative study |
| Q46276501 | Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement |
| Q30275688 | Genetic variants in CETP increase risk of intracerebral hemorrhage |
| Q37350985 | Genomic profiles of damage and protection in human intracerebral hemorrhage. |
| Q37180533 | Gradient echo MRI: implementation of a training tutorial for intracranial hemorrhage diagnosis |
| Q28297859 | Guidelines for the Early Management of Adults With Ischemic Stroke |
| Q90989101 | Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American S |
| Q34630199 | Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the A |
| Q48344070 | Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association |
| Q61891181 | Head CT and MRI Findings in Patients with Transient Ischemic Attacks |
| Q30412882 | Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage |
| Q36916223 | High rate of microbleed formation following primary intracerebral hemorrhage |
| Q35529945 | Hyperacute injury marker (HARM) in primary hemorrhage: a distinct form of CNS barrier disruption |
| Q36954992 | Hyperacute treatment initiation in neuroprotective agent stroke trials |
| Q56343865 | Hypertension and intracerebral hemorrhage recurrence among white, black, and Hispanic individuals |
| Q36512872 | Identification of Barriers to Stroke Awareness and Risk Factor Management Unique to Hispanics |
| Q28142169 | Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS) |
| Q34163344 | Image-guided endoscopic evacuation of spontaneous intracerebral hemorrhage. |
| Q30770221 | Imaging for prediction of functional outcome and assessment of recovery in ischemic stroke |
| Q37085104 | Imaging of intracranial haemorrhage |
| Q31032112 | Imaging of the brain and cerebral vasculature in patients with suspected stroke: advantages and disadvantages of CT and MRI. |
| Q30409698 | Imaging recommendations for acute stroke and transient ischemic attack patients: A joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery. |
| Q30411178 | Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery |
| Q41734141 | Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography |
| Q46355941 | In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up |
| Q56354690 | Influences Hematoma Volume and Outcome in Spontaneous Intracerebral Hemorrhage |
| Q46074331 | Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years. |
| Q78206652 | Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up |
| Q39716675 | Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. |
| Q30274923 | Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage |
| Q40620029 | Late secondary ischemic injury in patients receiving intraarterial thrombolysis |
| Q61891194 | MERCI 1 |
| Q48359573 | MRI biomarkers in acute ischemic stroke: a conceptual framework and historical analysis |
| Q53542718 | MRI replaces CT for stroke evaluation. |
| Q62716074 | Magnetic Resonance Imaging of Cerebrovascular Diseases |
| Q24676950 | Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison |
| Q33210344 | Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. |
| Q40667683 | Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application |
| Q83941781 | Magnetic resonance imaging for surrogate outcomes and patient selection |
| Q28270791 | Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial |
| Q30410308 | Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage |
| Q30209983 | Methodology for a community-based stroke preparedness intervention: the Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities Study |
| Q38673242 | Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis: Individual Patient Data Meta-Analysis. |
| Q80314173 | Mismatch and defuse: harvesting the riches of multicenter neuroimaging-based stroke studies |
| Q30415593 | Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke |
| Q37665049 | Multiparametric Magnetic Resonance Imaging for Prediction of Parenchymal Hemorrhage in Acute Ischemic Stroke After Reperfusion Therapy |
| Q48426582 | Neuroimaging demonstration of evolving small vessel ischemic injury in cerebral amyloid angiopathy |
| Q35757523 | Neuroimaging in TIAs |
| Q30428970 | Neuroimaging of cerebral ischemia and infarction |
| Q38173486 | Neurologic complications of cardiac tumors |
| Q35036473 | Neuroprotective agents for the treatment of acute ischemic stroke |
| Q44090198 | Novel insights into the genetics of intracerebral hemorrhage |
| Q82037477 | On our way to evidence-based medicine: impact of a neurointensive team on stroke outcomes |
| Q34280858 | Optimizing stroke clinical trial design: estimating the proportion of eligible patients |
| Q80847177 | PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events |
| Q92872317 | Patterns of Recovery From Aphasia in the First 2 Weeks After Stroke |
| Q61891206 | Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue |
| Q44607484 | Physician-investigator phone elicitation of consent in the field: a novel method to obtain explicit informed consent for prehospital clinical research |
| Q36279130 | Poor long-term blood pressure control after intracerebral hemorrhage |
| Q45949270 | Potential Role of Neuroprotective Agents in the Treatment of Patients with Acute Ischemic Stroke. |
| Q40554084 | Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke |
| Q48088025 | Predictors of apparent diffusion coefficient normalization in stroke patients |
| Q43901747 | Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis |
| Q35816637 | Predictors of highly prevalent brain ischemia in intracerebral hemorrhage |
| Q44195516 | Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial |
| Q36327014 | Preventing recurrence of thromboembolic events through coordinated treatment in the District of Columbia |
| Q48849676 | Progress in understanding white matter hyperintensities |
| Q35975171 | Racial differences by ischemic stroke subtype: a comprehensive diagnostic approach |
| Q24651019 | Racial differences in microbleed prevalence in primary intracerebral hemorrhage |
| Q35143249 | Racial disparities in tissue plasminogen activator treatment rate for stroke: a population-based study |
| Q28260139 | Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association |
| Q36816892 | Recruitment of black subjects for a natural history study of intracerebral hemorrhage |
| Q48427941 | Red meets white: do microbleeds link hemorrhagic and ischemic cerebrovascular disease? |
| Q38668262 | Reperfusion after ischemic stroke is associated with reduced brain edema |
| Q87117126 | Reply: To PMID 22367992 |
| Q61891084 | Response to Letter by Clawson et al |
| Q42735079 | Response to letter regarding article, "Association of chronic kidney disease with cerebral microbleeds in patients with primary intracerebral hemorrhage". |
| Q37222956 | Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial. |
| Q47226157 | Safety and cost of low-molecular-weight heparin as bridging anticoagulant therapy in subacute cerebral ischemia |
| Q28257163 | Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial |
| Q46682244 | Six-minute magnetic resonance imaging protocol for evaluation of acute ischemic stroke: pushing the boundaries |
| Q34151647 | Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project |
| Q45935920 | State of acute endovascular therapy: report from the 12th thrombolysis, thrombectomy, and acute stroke therapy conference. |
| Q30689276 | Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices |
| Q30410544 | The Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study protocol |
| Q46020386 | The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field. |
| Q36986795 | The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial |
| Q75828259 | The redefinition of TIA: the uses and limitations of DWI in acute ischemic cerebrovascular syndromes |
| Q41989030 | The role of CT and MRI in the emergency evaluation of persons with suspected stroke |
| Q61891233 | Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging |
| Q48619534 | Thrombolytic therapy of acute ischemic stroke during pregnancy |
| Q40119775 | Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke |
| Q53123887 | Tissue-Negative Transient Ischemic Attack: Is There a Role for Perfusion MRI? |
| Q54001515 | Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel disease. |
| Q43717461 | Treatment adherence rates one year after initiation of a systematic hospital-based stroke prevention program |
| Q46087072 | Trends in acute ischemic stroke trials through the 20th century |
| Q35088869 | Understanding reasons for delay in seeking acute stroke care in an underserved urban population |
| Q33715475 | Use of MRI in the Assessment of Patients with Stroke |
| Q38701519 | Use of Statins and Outcomes in Intracerebral Hemorrhage Patients |
| Q45972833 | Use of multimodal MRI and novel endovascular therapies in a patient ineligible for intravenous tissue plasminogen activator. |
| Q52956438 | Validation of computed tomographic middle cerebral artery "dot"sign: an angiographic correlation study. |
| Q35013583 | White matter ischemic changes in hyperacute ischemic stroke: voxel-based analysis using diffusion tensor imaging and MR perfusion |
| Q46428034 | Withdrawal of warfarin prior to a surgical procedure: time to follow the guidelines? |
Search more.